The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
On the antioxidant properties of kynurenic acid: Free radical scavenging activity and inhibition of oxidative stress
Abstract
Kynurenic acid (KYNA) is an endogenous metabolite of the kynurenine pathway for tryptophan degradation and an antagonist of both N-methyl-D-aspartate (NMDA) and alpha-7 nicotinic acetylcholine (α7nACh) receptors. KYNA has also been shown to scavenge hydroxyl radicals (OH) under controlled conditions of free radical production. In this work we evaluated the ability of KYNA to scavenge superoxide anion (O(2)(-)) and peroxynitrite (ONOO(-)). The scavenging ability of KYNA (expressed as IC(50) values) was as follows: OH=O(2)(-)>ONOO(-). In parallel, the antiperoxidative and scavenging capacities of KYNA (0-150 μM) were tested in cerebellum and forebrain homogenates exposed to 5 μM FeSO(4) and 2.5 mM 3-nitropropionic acid (3-NPA). Both FeSO(4) and 3-NPA increased lipid peroxidation (LP) and ROS formation in a significant manner in these preparations, whereas KYNA significantly reduced these markers. Reactive oxygen species (ROS) formation were determined in the presence of FeSO(4) and/or KYNA (0-100 μM), both at intra and extracellular levels. An increase in ROS formation was induced by FeSO(4) in forebrain and cerebellum in a time-dependent manner, and KYNA reduced this effect in a concentration-dependent manner. To further know whether the effect of KYNA on oxidative stress is independent of NMDA and nicotinic receptors, we also tested KYNA (0-100 μM) in a biological preparation free of these receptors - defolliculated Xenopus laevis oocytes - incubated with FeSO(4) for 1 h. A 3-fold increase in LP and a 2-fold increase in ROS formation were seen after exposure to FeSO(4), whereas KYNA attenuated these effects in a concentration-dependent manner. In addition, the in vivo formation of OH evoked by an acute infusion of FeSO(4) (100 μM) in the rat striatum was estimated by microdialysis and challenged by a topic infusion of KYNA (1 μM). FeSO(4) increased the striatal OH production, while KYNA mitigated this effect. Altogether, these data strongly suggest that KYNA, in addition to be a well-known antagonist acting on nicotinic and NMDA receptors, can be considered as a potential endogenous antioxidant.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“peripheral kynurenic acid may be involved in the pathophysiology of MDD through its antioxidative activity on reactive oxygen species (Lugo-Huitron et al., 2011).”
From Tryptophan-kynurenine and lipid related metabolites as blood biomarkers for first-episode drug-naïve patients with major depressive disorder: An exploratory pilot case-control study (2018) · cites this paper as Lugo-Huitron et al., 2011
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 316,394
Free radicals in biology and medicine
Gutteridge, J. M. C. (1991) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(91)90478-o · Cited by 17,178
Halliwell, B. B., Gutteridge, J. M. C., & Aruoma, O. I. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90222-3 · Cited by 2,372
[23] Oxidative chemistry of peroxynitrite
Beckman, J. S., Chen, J., Ischiropoulos, H., & Crow, J. P. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)33026-3 · Cited by 973
Free radicals in biology and medicine
Lucy, J. A. (1985) · FEBS Letters · doi:10.1016/0014-5793(85)80903-0 · Cited by 912
Parsons, C. G., Danysz, W., & Quack, G. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00019-2 · Cited by 900
Hilmas, C. J., Pereira, E. F. R., Alkondon, M., Rassoulpour, A., Schwarcz, R. M., & Albuquerque, E. X. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07463.2001 · Cited by 875
Perkins, M. N., & Stone, T. W. (1982) · Brain Research · doi:10.1016/0006-8993(82)91048-4 · Cited by 849
Endogenous kynurenines as targets for drug discovery and development
Stone, T. W., & Darlington, L. G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd870 · Cited by 768
Kynurenic Acid as a Ligand for Orphan G Protein-coupled Receptor GPR35
Wang, J., Simonavicius, N., Wu, X., Swaminath, G., Reagan, J. D., Tian, H., & Ling, L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603503200 · Cited by 708
Cited by
Sorted by citations
Kynurenines in the mammalian brain: when physiology meets pathology
Schwarcz, R., Bruno, J. P., Muchowski, P. J., & Wu, H.-Q. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3257 · Cited by 1,530
Kynurenines in the CNS: recent advances and new questions
Vécsei, L., Szalárdy, L., Fülöp, F., & Toldi, J. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3793 · Cited by 641
Inflammation, vitamin B6 and related pathways
Ueland, P. M., McCann, A., Midttun, Ø., & Ulvik, A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.08.001 · Cited by 394
Wirthgen, E., Hoeflich, A., Rebl, A., & Günther, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01957 · Cited by 401
Tryptophan-kynurenine pathway is dysregulated in inflammation and immune activation
Zou, M. (2015) · Frontiers in bioscience · doi:10.2741/4363 · Cited by 374
The kynurenine pathway and neurodegenerative disease
Maddison, D. C., & Giorgini, F. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.03.002 · Cited by 309
Won, E., & Kim, Y.-K. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208113006 · Cited by 300
The NMDA Receptor and Schizophrenia
Balu, D. T. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.006 · Cited by 303
Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis
Plitman, E., Iwata, Y., Caravaggio, F., Nakajima, S., Chung, J. K., Gerretsen, P., Kim, J., Takeuchi, H., Chakravarty, M. M., Remington, G. J., et al. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw221 · Cited by 255
Tanaka, M., Toldi, J., & Vécsei, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072431 · Cited by 229
The NMDA receptor ‘glycine modulatory site’ in schizophrenia: d-serine, glycine, and beyond
Balu, D. T., & Coyle, J. T. (2015) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2014.12.004 · Cited by 208
Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery
Moroni, F., Cozzi, A., Sili, M., & Mannaioni, G. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-011-0763-x · Cited by 213
Mitochondria, Oxidative Stress and the Kynurenine System, with a Focus on Ageing and Neuroprotection
Sas, K., Szabó, E., & Vécsei, L. (2018) · Molecules · doi:10.3390/molecules23010191 · Cited by 206
Salminen, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101573 · Cited by 207
Role of Kynurenine Pathway in Oxidative Stress during Neurodegenerative Disorders
Mor, A., Tankiewicz‐Kwedlo, A., Krupa, A., & Pawlak, D. (2021) · Cells · doi:10.3390/cells10071603 · Cited by 188
Fujigaki, H., Yamamoto, Y., & Saito, K. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.011 · Cited by 189
Kynurenine pathway metabolites and suicidality
Bryleva, E. Y., & Brundin, L. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.01.034 · Cited by 168
The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
Tan, L., Yu, J.-T., & Tan, L. (2012) · Journal of Neurological Sciences · doi:10.1016/j.jns.2012.08.005 · Cited by 151
Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease
Lim, C. K., Fernández-Gomez, F. J., Braidy, N., Estrada, C., Costa, C., Costa, S., Bessede, A., Fernandez-Villalba, E., Zinger, A., Herrero, M. T., et al. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.12.009 · Cited by 159
Kim, Y., & Won, E. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.020 · Cited by 160
Breda, C., Sathyasaikumar, K. V., Sograte‐Idrissi, S., Notarangelo, F. M., Estranero, J. G., Moore, G. G. L., Green, E. W., Kyriacou, C. P., Schwarcz, R. M., & Giorgini, F. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604453113 · Cited by 154
Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease
Chang, K., Cheng, M., Tang, H.-Y., Huang, C.-Y., Wu, Y., & Chen, C. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0845-3 · Cited by 152
Kynurenines with Neuroactive and Redox Properties: Relevance to Aging and Brain Diseases
Reyes-Ocampo, J. G., Lugo-Huitrón, R., González‐Esquivel, D. F., Ugalde‐Muñiz, P., Jiménez‐Anguiano, A., Pineda, B., Pedraza‐Chaverrí, J., Rı́os, C., & de la Cruz, V. P. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/646909 · Cited by 149
Self-citationInvolvement of the Kynurenine Pathway in Human Glioma Pathophysiology
Adams, S., Teo, C., McDonald, K. L., Zinger, A., Bustamante, S., Lim, C. K., Sundaram, G., Braidy, N., Brew, B. J., & Guillemin, G. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112945 · Cited by 149
Target- and Mechanism-Based Therapeutics for Neurodegenerative Diseases: Strength in Numbers
Trippier, P. C., Labby, K. J., Hawker, D. D., Mataka, J., & Silverman, R. B. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm3015926 · Cited by 141
Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?
Ostapiuk, A., & Urbanska, E. M. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13768 · Cited by 142
Associations between Melatonin, Neuroinflammation, and Brain Alterations in Depression
Won, E., Na, K., & Kim, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010305 · Cited by 149
Kynurenine pathway metabolites and enzymes involved in redox reactions
González‐Esquivel, D. F., Ortega, D. R., Pineda, B., Castro, N., Rı́os, C., & de la Cruz, V. P. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.03.013 · Cited by 141
Self-citationTargeted Deletion of Kynurenine 3-Monooxygenase in Mice
Giorgini, F., Huang, S.-Y., Sathyasaikumar, K. V., Notarangelo, F. M., Thomas, M. A. R., Tararina, M. A., Wu, H., Schwarcz, R. M., & Muchowski, P. J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.503813 · Cited by 138
Martin, K. S., Azzolini, M., & Ruas, J. L. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00580.2019 · Cited by 128
3-Hydroxykynurenine: An intriguing molecule exerting dual actions in the Central Nervous System
Colín-González, A. L., Maldonado, P. D., & Santamarı́a, A. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.11.007 · Cited by 121
Self-citationDoes kynurenic acid act on nicotinic receptors? An assessment of the evidence
Stone, T. W. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14907 · Cited by 123
Kynurenic acid and cancer: facts and controversies
Walczak, K., Wnorowski, A., Turski, W. A., & Plech, T. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03332-w · Cited by 118
Zádori, D., Veres, G., Szalárdy, L., Klivènyi, P., & Vécsei, L. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-170929 · Cited by 108
Wang, B., Lian, Y., Su, W., Wei, P., Dong, X. W., Liu, L.-L., Gong, H., Zhang, T., Jiang, C., & Wang, Y. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.11.017 · Cited by 105
Are Kynurenines Accomplices or Principal Villains in Dementia? Maintenance of Kynurenine Metabolism
Tanaka, M., Bohár, Z., & Vécsei, L. (2020) · Molecules · doi:10.3390/molecules25030564 · Cited by 107
Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
Kozieł, K., & Urbańska, E. M. (2023) · Cells · doi:10.3390/cells12030460 · Cited by 104
Structure–function relationships in human d-amino acid oxidase
Sacchi, S., Caldinelli, L., Cappelletti, P., Pollegioni, L., & Molla, G. (2012) · Amino Acids · doi:10.1007/s00726-012-1345-4 · Cited by 95
Kynurenine-3-monooxygenase: a review of structure, mechanism, and inhibitors
Smith, J. R., Jamie, J. F., & Guillemin, G. J. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.11.001 · Cited by 97
Role of Kynurenine Metabolism Pathway Activation in Major Depressive Disorders
Savitz, J. B. (2016) · Current topics in behavioral neurosciences · doi:10.1007/7854_2016_12 · Cited by 98
Yılmaz, C., Özdemir, F., & Gökmen, V. (2019) · LWT · doi:10.1016/j.lwt.2019.108655 · Cited by 91
Changing the Face of Kynurenines and Neurotoxicity: Therapeutic Considerations
Bohár, Z., Toldi, J., Fülöp, F., & Vécsei, L. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms16059772 · Cited by 89
The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
Hughes, T. D., Güner, O. F., Iradukunda, E. C., Phillips, R. S., & Bowen, J. P. (2022) · Molecules · doi:10.3390/molecules27010273 · Cited by 84
Current evidence linking diet to gut microbiota and brain development and function
Ceppa, F., Mancini, A., & Tuohy, K. M. (2018) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2018.1462309 · Cited by 83
Schwarcz, R. M. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.005 · Cited by 85
Reyes-Ocampo, J. G., Ortega, D. R., Cervantes, G. I. V., Pineda, B., Balderas, P. M. D. O., González‐Esquivel, D. F., Sánchez‐Chapul, L., Lugo-Huitrón, R., Silva‐Adaya, D., Rı́os, C., et al. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.08.003 · Cited by 80
Self-citationLarkin, P. B., Sathyasaikumar, K. V., Notarangelo, F. M., Funakoshi, H., Nakamura, T., Schwarcz, R. M., & Muchowski, P. J. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.07.002 · Cited by 82
Dhakar, N. K., Caldera, F., Bessone, F., Cecone, C., Pedrazzo, A. R., Cavalli, R., Dianzani, C., & Trotta, F. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115168 · Cited by 82
Glia in the cytokine-mediated onset of depression: fine tuning the immune response
Jo, W. K., Zhang, Y., Emrich, H. M., & Dietrich, D. E. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00268 · Cited by 81
Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond
Koola, M. M. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113409 · Cited by 77
IDO and TDO as a potential therapeutic target in different types of depression
Qin, Y., Wang, N., Zhang, X., Han, X., Zhai, X., & Lu, Y. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0290-7 · Cited by 79
The Tryptophan Pathway Targeting Antioxidant Capacity in the Placenta
Xu, K., Liu, G., & Fu, C. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1054797 · Cited by 76
Almulla, A. F., Supasitthumrong, T., Tunvirachaisakul, C., Algon, A. A. A., Al‐Hakeim, H. K., & Maes, M. H. J. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07582-1 · Cited by 71
Genestet, C., Gouëllec, A. L., Chaker, H., Polack, B., Guery, B. P., Toussaint, B., & Stasia, M. J. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.003 · Cited by 78
Yılmaz, C., & Gökmen, V. (2017) · Food Chemistry · doi:10.1016/j.foodchem.2017.10.004 · Cited by 70
Zhen, D., Liu, J., Zhang, X. D., & Song, Z. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.847611 · Cited by 70
Kuwano, N., Kato, T. A., Setoyama, D., Sato-Kasai, M., Shimokawa, N., Hayakawa, K., Ohgidani, M., Sagata, N., Kubo, H., Kishimoto, J., et al. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.01.014 · Cited by 69
Relevance of Alternative Routes of Kynurenic Acid Production in the Brain
Ramos-Chávez, L. A., Huitrón, R. L., Esquivel, D. G., Pineda, B., Ríos, C., Silva-Adaya, D., Sánchez-Chapul, L., Roldán-Roldán, G., & de la Cruz, V. P. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/5272741 · Cited by 62
Self-citationThe role and mechanism of tryptophan – kynurenine metabolic pathway in depression
Gong, X., Chang, R., Zou, J., Tan, S., & Huang, Z. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0047 · Cited by 72
Kynurenines in the Pathogenesis of Multiple Sclerosis: Therapeutic Perspectives
Biernacki, T., Sandi, D., Bencsik, K., & Vécsei, L. (2020) · Cells · doi:10.3390/cells9061564 · Cited by 68
Major Developments in the Design of Inhibitors along the Kynurenine Pathway
Jacobs, K. R., Castellano‐González, G., Guillemin, G. J., & Lovejoy, D. B. (2017) · Current Medicinal Chemistry · doi:10.2174/0929867324666170502123114 · Cited by 66
Kanchanatawan, B., Sirivichayakul, S., Ruxrungtham, K., Carvalho, A. F., Geffard, M., Ormstad, H., Anderson, G., & Maes, M. H. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0417-6 · Cited by 66
Danielski, L. G., Giustina, A. D., Goldim, M. P. D. S., Florentino, D., Mathias, K., Garbossa, L., Schraiber, R. D. B., Laurentino, A. O. M., da Silva, M. G., Michels, M., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0706-0 · Cited by 62
Szalárdy, L., Klivènyi, P., Zádori, D., Fülöp, F., Toldi, J., & Vécsei, L. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800167365 · Cited by 60
Glycyrrhizic acid ameliorates the kynurenine pathway in association with its antidepressant effect
Wang, B., Lian, Y., Dong, X. W., Wei, P., Liu, L.-L., Su, W., Gong, H., Zhang, T., Jiang, C., Li, J., et al. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.01.024 · Cited by 61
Kanchanatawan, B., Hemrungrojn, S., Thika, S., Sirivichayakul, S., Ruxrungtham, K., Carvalho, A. F., Geffard, M., Anderson, G., & Maes, M. H. J. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0751-8 · Cited by 60
An exceptionally high content of kynurenic acid in chestnut honey and flowers of chestnut tree
Turski, M. P., Chwil, S., Turska, M., Chwil, M., Kocki, T., Rajtar, G., & Parada-Turska, J. (2016) · Journal of Food Composition and Analysis · doi:10.1016/j.jfca.2016.02.003 · Cited by 60
Tanaka, M., Szabó, Á., & Vécsei, L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312767 · Cited by 65
Pocivavsek, A., Schwarcz, R. M., & Erhardt, S. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000239 · Cited by 63
Sodhi, R. K., Bansal, Y., Singh, R., Saroj, P., Bhandari, R., Kumar, B., & Kuhad, A. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.03.009 · Cited by 57
The weight of nutrients: kynurenine metabolites in obesity and exercise
Dadvar, S., Ferreira, D. M. S., Červenka, I., & Ruas, J. L. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12830 · Cited by 59
Tuka, B., Nyári, A., Cseh, E. K., Körtési, T., Veréb, D., Tömösi, F., Kecskeméti, G., Janáky, T., Tajti, J., & Vécsei, L. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01239-1 · Cited by 61
Redox Properties of Tryptophan Metabolism and the Concept of Tryptophan Use in Pregnancy
Xu, K., Liu, H., Bai, M., Gao, J., Wu, X., & Yin, Y. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071595 · Cited by 55
Kynurenine Pathway Metabolites as Biomarkers for Amyotrophic Lateral Sclerosis
Tan, V. X., & Guillemin, G. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01013 · Cited by 54
An Emerging Cross-Species Marker for Organismal Health: Tryptophan-Kynurenine Pathway
Jamshed, L., Debnath, A., Jamshed, S., Wish, J. V., Raine, J. C., Tomy, G. T., Thomas, P. J., & Holloway, A. C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116300 · Cited by 59
Hosseinalizadeh, H., Mahmoodpour, M., Samadani, A. A., & Roudkenar, M. H. (2022) · Medical Oncology · doi:10.1007/s12032-022-01724-w · Cited by 57
The Role of the Kynurenine/AhR Pathway in Diseases Related to Metabolism and Cancer
Shadboorestan, A., Koual, M., Dairou, J., & Coumoul, X. (2023) · International Journal of Tryptophan Research · doi:10.1177/11786469231185102 · Cited by 58
Liu, J., Ching, J., Wee, H. N., Liu, S., Gurung, R. L., Lee, J., Yiamunaa, M., Zheng, H., Lee, L. S., Ang, K., et al. (2023) · Diabetes Care · doi:10.2337/dc23-1147 · Cited by 59
Turner, J. A., Fredrickson, M. A., D’Antonio, M. A., Katsnelson, E. N., MacBeth, M. L., Gulick, R. J. V., Chimed, T.-S., McCarter, M., D’Alessandro, A., Robinson, W. A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38933-4 · Cited by 57
Alternative kynurenic acid synthesis routes studied in the rat cerebellum
Ayala, T. B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00178 · Cited by 52
Ferreira, F. S., Biasibetti, H., Pierozan, P., Schmitz, F., Bertó, C. G., Prezzi, C. A., Manfredini, V., & Wyse, Â. T. D. S. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1003-2 · Cited by 53
Bratek, E., Ziembowicz, A., Godlewski, J. A., & Salińska, E. (2021) · Antioxidants · doi:10.3390/antiox10111775 · Cited by 50
The Function of the Kynurenine Pathway in the Placenta: A Novel Pharmacotherapeutic Target?
Broekhuizen, M., Danser, A. H. J., Reiss, I. K. M., & Merkus, D. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111545 · Cited by 53
Antioxidant Properties of Kynurenines: Density Functional Theory Calculations
Zhuravlev, A. V., Zakharov, G. A., Щеголев, Б. Ф., & Savvateeva-Popova, E. V. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005213 · Cited by 49
The role of the kynurenine pathway and quinolinic acid in adolescent major depressive disorder
Öztürk, M., Sapmaz, Ş. Y., Kandemır, H., Taneli, F., & Aydemır, Ö. (2020) · International Journal of Clinical Practice · doi:10.1111/ijcp.13739 · Cited by 50
Potato- An Important Source of Nutritional Kynurenic Acid
Turski, M. P., Kamiński, P., Zgrajka, W., Turska, M., & Turski, W. A. (2012) · Plant Foods for Human Nutrition · doi:10.1007/s11130-012-0283-3 · Cited by 48
Sandi, D., Fricska‐Nagy, Z., Bencsik, K., & Vécsei, L. (2021) · Molecules · doi:10.3390/molecules26113423 · Cited by 51
Réus, G. Z., Becker, I. R. T., Scaini, G., Petronilho, F. C., Oses, J. P., Kaddurah‐Daouk, R., Ceretta, L. B., Zugno, A. I., Dal‐Pizzol, F., Quevedo, J., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.10.009 · Cited by 47
Baratta, A. M., Buck, S. A., Buchla, A. D., Fabian, C. B., Chen, S., Mong, J. A., & Pocivavsek, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-25288-w · Cited by 46
Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization via GPR35
Sun, T., Xie, R.-Q., He, H., Xie, Q., Zhao, X., Kang, G., Chen, C., Yin, W., Cong, J., Li, J., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1019365 · Cited by 46
Ramírez-Ortega, D., Ramiro-Salazar, A., González-Esquivel, D., Ríos, C., Pineda, B., & de la Cruz, V. P. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2371895 · Cited by 39
Self-citationAl-Nemi, R., Makki, A. A., Sawalha, K., Hajjar, D., & Jaremko, M. (2022) · Metabolites · doi:10.3390/metabo12050451 · Cited by 42
Kynurenic Acid Protects against Thioacetamide-Induced Liver Injury in Rats
Marciniak, S., Wnorowski, A., Smolińska, K., Walczyna, B., Turski, W. A., Kocki, T., Paluszkiewicz, P., & Parada-Turska, J. (2018) · Analytical Cellular Pathology · doi:10.1155/2018/1270483 · Cited by 44
Ramos-Chávez, L. A., Roldán-Roldán, G., García-Juárez, B., González‐Esquivel, D. F., de la Cruz, G. P., Pineda, B., Ortega, D. R., Muñoz, I. G., Herrera, B. J., Rı́os, C., et al. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/8604718 · Cited by 45
Self-citationSchwieler, L., Trepci, A., Krzyżanowski, S., Hermansson, S., Granqvist, M., Piehl, F., Venckūnas, T., Brazaitis, M., Kamandulis, S., Lindqvist, D., et al. (2020) · Bioanalysis · doi:10.4155/bio-2019-0303 · Cited by 43
Su, T., Tan, Y., Tsui, M.-S., Hua, Y., Fu, X., Li, T., Chan, C. L., Guo, H., Li, Y., Zhu, P., et al. (2016) · Scientific Reports · doi:10.1038/srep34692 · Cited by 42
Photochemistry of aqueous solutions of kynurenic acid and kynurenine yellow
Zelentsova, E. A., Sherin, P. S., Snytnikova, O. A., Kaptein, R., Vauthey, E., & Tsentalovich, Y. P. (2012) · Photochemical & Photobiological Sciences · doi:10.1039/c2pp25357g · Cited by 41
Neuronal Loss of the Glutamate Transporter GLT-1 Promotes Excitotoxic Injury in the Hippocampus
Rimmele, T. S., Li, S., Andersen, J. V., Westi, E. W., Rotenberg, A., Wang, J., Aldana, B. I., Selkoe, D. J., Aoki, C. J., Dulla, C. G., et al. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.788262 · Cited by 41
Ortega, D. R., Ugalde‐Muñiz, P., Ayala, T. B., Cervantes, G. I. V., Lugo-Huitrón, R., Pineda, B., González‐Esquivel, D. F., de la Cruz, G. P., Pedraza‐Chaverrí, J., Sánchez‐Chapul, L., et al. (2021) · Antioxidants · doi:10.3390/antiox11010031 · Cited by 43
Self-citationThe Role of Inflammation in the Pathophysiology of Depression and Suicidal Behavior
Serafini, G., Costanza, A., Aguglia, A., Amerio, A., Trabucco, A., Escelsior, A., Sher, L., & Amore, M. (2022) · Medical Clinics of North America · doi:10.1016/j.mcna.2022.09.001 · Cited by 48
Metadata
- Authors
- Lugo-Huitrón, R., Blanco-Ayala, T., Ugalde-Muñiz, P., Carrillo-Mora, P., Pedraza-Chaverrí, J., Silva-Adaya, D., Maldonado, P. D., Torres, I., Pinzón, E., Ortiz-Islas, E., López, T., García, E., Pineda, B., Torres-Ramos, M., Santamaría, A., & La Cruz, V. P.-D.
- Affiliations
- Instituto Nacional de Neurología y Neurocirugía (MX)
- Universidad Nacional Autónoma de México (MX)
- Venue
- Neurotoxicology and Teratology
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 33
- Issue
- 5
- Pages
- 538-547
- ISSN
- 0892-0362 (ISSN-L)
- OpenAlex
- W2087714907
- Cited by
- 346
- References
- 59
- Citations by year
- 2026: 25 · 2025: 21 · 2024: 29 · 2023: 34 · 2022: 40 · 2021: 40 · 2020: 18 · 2019: 18 · 2018: 27 · 2017: 22 · 2016: 23 · 2015: 16 · 2014: 12 · 2013: 9 · 2012: 11
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurotoxicology and Teratology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Physical Sciences › Chemistry › Organic Chemistry › Free Radicals and Antioxidants
- Health Sciences › Medicine › Biochemistry (medical) › Phytochemicals and Antioxidant Activities
- Keywords
- kynurenic acid, antioxidant activity, free radical scavenging, oxidative stress, lipid peroxidation, reactive oxygen species, superoxide, peroxynitrite, hydroxyl radicals, NMDA receptor antagonists, alpha7 nicotinic acetylcholine receptor, kynurenine pathway, tryptophan metabolism, 3-nitropropionic acid, iron-induced oxidative stress
- MeSH terms
- Animals, Antioxidants, Cells, Cultured, Cerebellum, Corpus Striatum, Dose-Response Relationship, Drug, Ferrous Compounds, Hydroxides, Kynurenic Acid, Male, Microinjections, Nitro Compounds, Oocytes, Propionates, Xenopus laevis, Lipid Peroxidation, Free Radical Scavengers, Prosencephalon, Rats, Wistar, Reactive Oxygen Species, Oxidative Stress, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
